Adaptive Biotechnologies Corporation
ADPT
$24.66
$0.321.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.96% | -1.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.96% | -1.13% | |||
| Cost of Revenue | -7.12% | 5.86% | |||
| Gross Profit | 12.93% | -9.94% | |||
| SG&A Expenses | 0.53% | 7.48% | |||
| Depreciation & Amortization | 0.95% | -2.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.06% | 6.66% | |||
| Operating Income | 17.89% | -50.36% | |||
| Income Before Tax | -99.56% | -47.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -99.56% | -47.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 950.00% | -- | |||
| Net Income | -98.61% | -47.53% | |||
| EBIT | 17.89% | -50.36% | |||
| EBITDA | 21.43% | -79.17% | |||
| EPS Basic | -93.25% | -45.21% | |||
| Normalized Basic EPS | 23.06% | -43.29% | |||
| EPS Diluted | -93.25% | -39.70% | |||
| Normalized Diluted EPS | 23.06% | -43.29% | |||
| Average Basic Shares Outstanding | 2.79% | 1.56% | |||
| Average Diluted Shares Outstanding | 2.79% | 1.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||